Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma
Abstract Compelling evidence shows that the frequency of T cells in the tumor microenvironment correlates with prognosis as well as response to immunotherapy. However, considerable heterogeneity exists within tumor-infiltrating T cells, and significance of their genomic and transcriptomic landscape...
Main Authors: | Takaaki Oba, Mark D. Long, Ken-ichi Ito, Fumito Ito |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-50062-y |
Similar Items
-
Negative regulation of humoral immunity due to interplay between the SLAMF1, SLAMF5, and SLAMF6 receptors
by: Ninghai eWang, et al.
Published: (2015-04-01) -
The Advantage of Using an Optical See-Through Head-Mounted Display in Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized Study
by: Tadafumi Shimizu, et al.
Published: (2023-01-01) -
SLAMF6 is associated with the susceptibility and severity of rheumatoid arthritis in the Chinese population
by: Guodong Xia, et al.
Published: (2022-01-01) -
Multiomics characterization of pyroptosis in the tumor microenvironment and therapeutic relevance in metastatic melanoma
by: Wenqiong Chen, et al.
Published: (2024-01-01) -
SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint
by: Emma Hajaj, et al.
Published: (2020-03-01)